nifedipine has been researched along with Cold Fingers, Hereditary in 156 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nifedipine reduces forearm vascular resistance dose-dependently when infused into the brachial artery in patients with essential hypertension, attesting to its potent arterial vasodilator effects." | 10.16 | Use of nifedipine in hypertension and Raynaud's phenomenon. ( Bühler, FR; Erne, P; Kiowski, W, 1990) |
| "To describe a patient who was diagnosed with Raynaud's phenomenon, was prescribed immediate-release nifedipine, and developed a possible erythromelalgia-like syndrome." | 7.69 | Possible erythromelalgia-like syndrome associated with nifedipine in a patient with Raynaud's phenomenon. ( Gora-Harper, ML; Nash, KS; Sunahara, JF, 1996) |
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 7.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "During the Nifedipine period, the number of attacks, their intensity and resulting total disability decreased significantly, and hyperemia increased significantly." | 7.67 | [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon]. ( Baudot, N; Blaison, N; Evenou, P; Gilard, M; Mathieu, JF; Vayssairat, M, 1989) |
| " Nifedipine reduces forearm vascular resistance dose-dependently when infused into the brachial artery in patients with essential hypertension, attesting to its potent arterial vasodilator effects." | 6.16 | Use of nifedipine in hypertension and Raynaud's phenomenon. ( Bühler, FR; Erne, P; Kiowski, W, 1990) |
| " A patient is described who had POEMS syndrome with precapillary pulmonary hypertension and Raynaud's phenomenon, and who responded well to a short course of corticosteroids and long term nifedipine." | 4.80 | Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy? ( Bossone, E; Erba, H; Paciocco, G; Rubenfire, M, 2000) |
| "To investigate an association between syncope and Raynaud's disease (RD), its clinical features, and the effect of treatment with nifedipine." | 3.78 | Syncope and Raynaud's disease. ( Angus-Leppan, H; Guiloff, RJ; Rajakulendran, S, 2012) |
| "To describe a patient who was diagnosed with Raynaud's phenomenon, was prescribed immediate-release nifedipine, and developed a possible erythromelalgia-like syndrome." | 3.69 | Possible erythromelalgia-like syndrome associated with nifedipine in a patient with Raynaud's phenomenon. ( Gora-Harper, ML; Nash, KS; Sunahara, JF, 1996) |
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 3.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "During the Nifedipine period, the number of attacks, their intensity and resulting total disability decreased significantly, and hyperemia increased significantly." | 3.67 | [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon]. ( Baudot, N; Blaison, N; Evenou, P; Gilard, M; Mathieu, JF; Vayssairat, M, 1989) |
| "We studied (via acute vasodilator testing with nifedipine) 27 patients with pulmonary arterial hypertension (PAH) (11 primary, 16 secondary PAH, [including six patients with Raynaud's phenomenon]) in order to identify predictors of hemodynamic response and specifically to assess whether patients with Raynaud's phenomenon and pulmonary hypertension were more likely to respond to nifedipine." | 3.67 | Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon. ( Borer, JS; Fisher, J; Likier, HM; Mack, RJ; Schiff, AN, 1987) |
| "nifedipine SR was more effective than Ginkgo biloba extract for treatment of primary RP in Korean patients." | 2.74 | To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study). ( Choi, CJ; Choi, WS; Chung, JH; Kim, CM; Kim, KS; Lee, JB; Lee, JH; Ock, SM; Song, CH, 2009) |
| "The study cohort included patients with systemic sclerosis (SSc; n = 20), primary Raynaud's phenomenon (n = 15) or 'autoimmune Raynaud's' (n = 5)." | 2.69 | Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. ( Black, CM; Bruckdorfer, KR; Bunce, TD; Denton, CP; Dorado, MB; Howell, K; Roberts, Z; Wilson, H, 1999) |
| "Nifedipine-treated participants showed a 66% reduction in verified attacks compared with placebo recipients (P<." | 2.69 | Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up. ( , 2000) |
| "Misoprostol was similar to nifedipine for the treatment of Raynaud phenomenon secondary to systemic diseases and can be a therapeutic alternative for these patients." | 2.68 | [Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex]. ( Castillo Palma, MJ; Sánchez-Román, J; Talegón Meléndez, A; Varela-Aguilar, JM, 1997) |
| "Nifedipine treatment per se significantly increased circulating noradrenaline in both the primary Raynaud's phenomenon patient group and in the control group (from 0." | 2.67 | Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls. ( Edvinsson, L; Hedner, T; Leppert, J; Myrdal, U; Nilsson, H; Ringqvist, I, 1993) |
| " Such a procedure might be more effective and safer than chronic intake of higher doses of nifedipine, as currently recommended in Raynaud's attacks." | 2.67 | Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease. ( Bounameaux, H; Weber, A, 1990) |
| "Patients with systemic sclerosis reacted as well as patients with primary Raynaud's phenomenon." | 2.66 | Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects. ( Thien, T; van 't Laar, A; Wollersheim, H, 1987) |
| "Nifedipine and placebo were given in random order for two consecutive four-week periods." | 2.66 | A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon. ( Corbin, DO; Housley, E; Macintyre, CC; Wood, DA, 1986) |
| "Nifedipine was given as a 20 mg biphasic release formulation twice daily." | 2.66 | Clinical and rheological effects of nifedipine in Raynaud's phenomenon. ( Challenor, VF; Francis, DA; Roath, OS; Waller, DG, 1986) |
| "Nisoldipine was given at doses of 5 mg and 10 mg daily for one month each in a placebo controlled double-blind cross-over trial." | 2.66 | Nisoldipine in primary Raynaud's phenomenon. ( Challenor, VF; Francis, DA; Francis, JL; Mani, R; Roath, S; Waller, DG, 1987) |
| " The effect size may have been small because of low dosing in studies." | 2.43 | Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. ( Pope, JE; Thompson, AE, 2005) |
| "We first screened all drugs associated with at least 1 case of erythromelalgia, an adverse effect opposite to RP." | 1.56 | Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database. ( Charles, K; Jean-Luc, C; Matthieu, R; Zaza, P, 2020) |
| "Patients with Raynaud phenomenon, even in the absence of systemic disease, are frequently treated by rheumatologists." | 1.37 | Raynaud phenomenon of the nipple: a rare finding in rheumatology clinic. ( Keith, MP; O'Sullivan, S, 2011) |
| "In patients with systemic sclerosis or mixed connective tissue disease (MCTD) acral ulcers are considered as frequent manifestations that may lead to amputation and loss of function, respectively, as a result of secondary Raynaud's phenomenon." | 1.36 | [Treatment options of acral ulcers in MCTD]. ( Girndt, M; Herink, AK; Keysser, G; Köthe, L, 2010) |
| "Breast pain is a common complaint among lactating women." | 1.33 | Vasospasm of the nipple presenting as painful lactation. ( McKenna, DS; Page, SM, 2006) |
| "Iloprost was reported by the patients as beneficial in 49 (58%) of 84 cases, whereas only 36 (43%) of the 84 patients had previously found any other treatment to be useful." | 1.28 | Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon. ( Belcher, G; Watson, HR, 1991) |
| "In the normal subjects reactive hyperemia was greatest at 20-22 degrees C." | 1.27 | Reactive hyperemia in patients with Raynaud's phenomenon. ( Kappagoda, T; Russell, A, 1988) |
| "Verapamil was least efficient and exerted a weak vasoactive action." | 1.27 | [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists]. ( Shcherbakov, AB, 1988) |
| "Nifedipine was shown to inhibit mitogen-induced lymphocyte proliferation but only in patients who responded to the drug clinically." | 1.27 | Clinical and laboratory effects of nifedipine in Raynaud's phenomenon. ( Black, CM; Hall, ND; Hawkins, SJ; Maddison, PJ; McGregor, A; Ring, EF, 1986) |
| "The serum concentrations and urinary excretion of nifedipine and 3 of its metabolites have been compared in two groups of hypertensive patients, one receiving prolonged (1-2 years) nifedipine monotherapy, the second receiving the same dosage of nifedipine in conjunction with a variety of other antihypertensive and cardioactive drugs." | 1.27 | The metabolism of nifedipine during long-term therapy. ( Fernandez, PG; Nath, C; Snedden, W, 1986) |
| "Nifedipine was shown to be effective in reducing both the frequency and the severity of Raynaud's phenomenon, whereas prazosin was ineffective." | 1.27 | Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon. ( Amor, B; Degeorges, M; Foult, JM; Kahan, A; Menkes, CJ; Weber, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 84 (53.85) | 18.7374 |
| 1990's | 28 (17.95) | 18.2507 |
| 2000's | 23 (14.74) | 29.6817 |
| 2010's | 16 (10.26) | 24.3611 |
| 2020's | 5 (3.21) | 2.80 |
| Authors | Studies |
|---|---|
| Zaza, P | 1 |
| Matthieu, R | 1 |
| Jean-Luc, C | 1 |
| Charles, K | 1 |
| Varghese, B | 1 |
| Chew, E | 1 |
| Konig, MF | 1 |
| Anderson, PO | 1 |
| Gallego, H | 1 |
| Aleshaki, JS | 1 |
| Drobek, HH | 1 |
| Porwolik, M | 1 |
| Pietrauszka, K | 1 |
| Miziołek, B | 1 |
| Bergler-Czop, B | 1 |
| Brzezińska-Wcisło, L | 1 |
| Rirash, F | 1 |
| Tingey, PC | 1 |
| Harding, SE | 1 |
| Maxwell, LJ | 1 |
| Tanjong Ghogomu, E | 1 |
| Wells, GA | 1 |
| Tugwell, P | 1 |
| Pope, J | 6 |
| Wortsman, X | 1 |
| Del Barrio-Díaz, P | 1 |
| Meza-Romero, R | 1 |
| Poehls-Risco, C | 1 |
| Vera-Kellet, C | 1 |
| Bari, A | 1 |
| Zeeshan, F | 1 |
| Hanif, G | 1 |
| Jabeen, U | 1 |
| Bano, I | 1 |
| Rathore, AW | 1 |
| Jansen, S | 1 |
| Sampene, K | 1 |
| Butendieck, RR | 1 |
| Murray, PM | 1 |
| Ennis, H | 2 |
| Anderson, ME | 2 |
| Wilkinson, J | 2 |
| Herrick, AL | 2 |
| Bruni, C | 1 |
| Lepri, G | 1 |
| Peruzzi, F | 1 |
| Bellando-Randone, S | 1 |
| Radicati, A | 1 |
| Matucci-Cerinic, M | 1 |
| Guiducci, S | 1 |
| Senel, S | 1 |
| Zorlu, P | 1 |
| Dogan, B | 1 |
| Acar, M | 1 |
| Hughes, M | 1 |
| Agbor, VN | 1 |
| Njim, T | 1 |
| Aminde, LN | 1 |
| Choi, WS | 1 |
| Choi, CJ | 1 |
| Kim, KS | 1 |
| Lee, JH | 1 |
| Song, CH | 1 |
| Chung, JH | 1 |
| Ock, SM | 1 |
| Lee, JB | 1 |
| Kim, CM | 1 |
| Pope, JE | 3 |
| Velstra, B | 2 |
| Bijlsma, TS | 2 |
| Herink, AK | 1 |
| Köthe, L | 1 |
| Girndt, M | 1 |
| Keysser, G | 1 |
| O'Sullivan, S | 1 |
| Keith, MP | 1 |
| Guiloff, RJ | 1 |
| Rajakulendran, S | 1 |
| Angus-Leppan, H | 1 |
| Wu, M | 1 |
| Chason, R | 1 |
| Wong, M | 1 |
| Thompson, B | 3 |
| Jacob, RG | 2 |
| Frederick, M | 3 |
| Geller, NV | 1 |
| Hunsberger, S | 2 |
| Garrison, CP | 1 |
| Anderson, JE | 1 |
| Held, N | 1 |
| Wright, K | 1 |
| Thompson, AE | 1 |
| Tagliarino, H | 1 |
| Purdon, M | 1 |
| Jamieson, B | 1 |
| Hoekzema, G | 1 |
| Page, SM | 1 |
| McKenna, DS | 1 |
| Yucel, B | 1 |
| Uzum, AK | 1 |
| Ozbey, N | 1 |
| Kamali, S | 1 |
| Yager, J | 1 |
| Schwagten, B | 1 |
| Verheye, S | 1 |
| Van den Heuvel, P | 1 |
| Buell, C | 1 |
| Tobinick, E | 1 |
| Lamp, K | 1 |
| Fontenelle, SM | 1 |
| Kayser, C | 1 |
| Pucinelli, ML | 1 |
| Andrade, LE | 1 |
| Smith, CD | 1 |
| McKendry, RJ | 1 |
| Kahan, A | 6 |
| Weber, S | 5 |
| Amor, B | 6 |
| Saporta, L | 3 |
| Hodara, M | 3 |
| Degeorges, M | 5 |
| Rodeheffer, RJ | 3 |
| Rommer, JA | 1 |
| Wigley, F | 1 |
| Smith, CR | 3 |
| Guerin, F | 2 |
| Menkes, CJ | 3 |
| Müller-Bühl, U | 1 |
| Diehm, C | 1 |
| Scheuermann, W | 1 |
| Mörl, H | 1 |
| Baadsgaard, O | 1 |
| Schmidt, JF | 2 |
| Ironmann, L | 1 |
| Pisenti, L | 1 |
| Hart, LL | 1 |
| Sauza, J | 1 |
| Kraus, A | 2 |
| González-Amaro, R | 1 |
| Alarcón-Segovia, D | 1 |
| Creager, MA | 2 |
| Pariser, KM | 2 |
| Winston, EM | 1 |
| Rasmussen, HM | 1 |
| Miller, KB | 2 |
| Coffman, JD | 1 |
| Day, TW | 1 |
| Mendoza, F | 1 |
| Maguire, FW | 1 |
| Ettinger, WH | 2 |
| Wise, RA | 4 |
| Schaffhauser, D | 1 |
| Wigley, FM | 5 |
| Winston, EL | 1 |
| Salem, DN | 1 |
| Nilsson, H | 4 |
| Jonasson, T | 1 |
| Ringqvist, I | 5 |
| Sarkozi, J | 2 |
| McCarthy, DD | 1 |
| Lee, P | 1 |
| Pierce, EH | 1 |
| Valle, RD | 1 |
| Wielenga, J | 1 |
| Conner, CS | 1 |
| Jaffe, IA | 1 |
| Myrdal, U | 2 |
| Leppert, J | 4 |
| Edvinsson, L | 3 |
| Ekman, R | 1 |
| Hedner, T | 3 |
| Gasser, P | 2 |
| Niklasson, U | 1 |
| Gross, JS | 1 |
| Shua-Haim, JR | 1 |
| Smilde, TJ | 1 |
| Wollersheim, H | 3 |
| Aikimbaev, KS | 1 |
| Oğuz, M | 1 |
| Ozbek, S | 1 |
| Demirtaş, M | 1 |
| Birand, A | 1 |
| Batyraliev, T | 1 |
| Sunahara, JF | 1 |
| Gora-Harper, ML | 1 |
| Nash, KS | 1 |
| Weber, KT | 1 |
| Lawlor-Smith, LS | 1 |
| Lawlor-Smith, CL | 1 |
| Varela-Aguilar, JM | 1 |
| Sánchez-Román, J | 1 |
| Talegón Meléndez, A | 1 |
| Castillo Palma, MJ | 1 |
| Ho, M | 1 |
| Belch, JJ | 4 |
| Sturgill, MG | 1 |
| Seibold, JR | 1 |
| Léger, P | 5 |
| Geller, NL | 1 |
| Hill, R | 2 |
| Smith, EA | 2 |
| Kaufmann, P | 1 |
| Freedman, RR | 1 |
| Bielory, L | 1 |
| Denton, CP | 3 |
| Bunce, TD | 1 |
| Dorado, MB | 1 |
| Roberts, Z | 1 |
| Wilson, H | 1 |
| Howell, K | 3 |
| Bruckdorfer, KR | 1 |
| Black, CM | 4 |
| Alexopoulos, V | 1 |
| Kollias, S | 1 |
| Boccalon, H | 4 |
| Csiki, Z | 1 |
| Maniewski, R | 1 |
| Lewandowski, P | 1 |
| Liebert, A | 1 |
| Bendayan, P | 3 |
| Bajorski, L | 1 |
| Möller, KO | 2 |
| Popivanov, D | 1 |
| Mineva, A | 1 |
| Stefanovska, A | 1 |
| Bracic, M | 1 |
| Bracic, T | 1 |
| Dziadzio, M | 1 |
| Smith, R | 1 |
| Blann, A | 2 |
| Bowers, E | 1 |
| Paciocco, G | 1 |
| Bossone, E | 1 |
| Erba, H | 1 |
| Rubenfire, M | 1 |
| Maricq, HR | 1 |
| Jennings, JR | 1 |
| Valter, I | 1 |
| Konychev, AV | 1 |
| Koreshkina, TA | 1 |
| Kokorin, KV | 1 |
| Kaiukov, AV | 1 |
| Coleiro, B | 1 |
| Marshall, SE | 1 |
| Welsh, KI | 1 |
| Pola, P | 1 |
| Savi, L | 1 |
| Dal Lago, A | 1 |
| Zucchiatti, V | 1 |
| Koller-Benz, G | 1 |
| Fritzsche, A | 1 |
| Krapf, R | 1 |
| Cooke, ED | 2 |
| Nicolaides, AN | 1 |
| Weber, A | 1 |
| Bounameaux, H | 1 |
| Watson, HR | 1 |
| Belcher, G | 1 |
| Alpert, MA | 2 |
| Pressly, TA | 2 |
| Mukerji, V | 2 |
| Lambert, CR | 1 |
| Mukerji, B | 1 |
| Panayiotou, H | 1 |
| Sharp, GC | 2 |
| Kiowski, W | 1 |
| Erne, P | 1 |
| Bühler, FR | 1 |
| O'Dowd, A | 1 |
| Forbes, CD | 1 |
| Sturrock, RD | 1 |
| Guseva, NG | 3 |
| Poltyrev, AS | 1 |
| Alekseev, VI | 1 |
| Anikina, NV | 1 |
| Shcherbakov, AB | 4 |
| Gush, RJ | 1 |
| Taylor, LJ | 1 |
| Jayson, MI | 1 |
| Rademaker, M | 2 |
| Almond, NE | 1 |
| Beacham, JA | 1 |
| Smith, RE | 1 |
| Mant, TG | 1 |
| Kirby, JD | 2 |
| Kaya, IS | 1 |
| Senses, DA | 1 |
| Dilmen, U | 1 |
| Vayssairat, M | 1 |
| Blaison, N | 1 |
| Baudot, N | 1 |
| Evenou, P | 1 |
| Gilard, M | 1 |
| Mathieu, JF | 1 |
| Codella, O | 1 |
| Caramaschi, P | 1 |
| Olivieri, O | 1 |
| Perbellini, L | 1 |
| Perbellini, A | 1 |
| Bambara, LM | 1 |
| Corrocher, R | 1 |
| De Sandre, G | 1 |
| Challenor, VF | 4 |
| Waller, DG | 4 |
| Hayward, RA | 1 |
| Griffin, MJ | 1 |
| Roath, OS | 3 |
| Berden, J | 1 |
| Thien, T | 2 |
| Valentin, N | 1 |
| Nielsen, SL | 3 |
| Sukharevskaia, TM | 1 |
| Loseva, MI | 1 |
| Pakhomova, AM | 1 |
| Bolotnova, TV | 1 |
| Riccio, A | 2 |
| Pennarola, R | 1 |
| Farinaro, C | 2 |
| Scherillo, G | 1 |
| Infranzi, E | 1 |
| Del Puente, A | 2 |
| Oriente, P | 2 |
| Finch, MB | 2 |
| Copeland, S | 1 |
| Passmore, AP | 1 |
| Johnston, GD | 2 |
| Malamet, R | 3 |
| Burns, EC | 1 |
| Dunger, DB | 1 |
| Dillon, MJ | 1 |
| Andersen, LB | 1 |
| Thestrup-Pedersen, K | 1 |
| Sell, A | 1 |
| Barr, WG | 1 |
| Fahey, PJ | 1 |
| Francis, JL | 2 |
| Russell, A | 1 |
| Kappagoda, T | 1 |
| Mach, ES | 2 |
| Kallenberg, CG | 2 |
| Wouda, AA | 2 |
| Kuitert, JJ | 2 |
| Tijssen, J | 2 |
| Wesseling, H | 2 |
| Meyrick Thomas, RH | 1 |
| Grimes, SM | 1 |
| MacKay, A | 1 |
| Kovacs, IB | 1 |
| Cook, ED | 1 |
| Bowcock, SM | 1 |
| Rozwodowska, M | 1 |
| Polaszewska-Muszyńska, M | 1 |
| Ukleja-Adamowicz, M | 1 |
| Rewakowicz, M | 1 |
| Guzowska, M | 1 |
| Marunowska, A | 1 |
| Jundziłł, W | 1 |
| Wodyńska, T | 1 |
| Ruchalski, M | 1 |
| Strzelecki, A | 1 |
| Hantel, A | 1 |
| Rowinsky, EK | 1 |
| Donehower, RC | 1 |
| Flammer, J | 1 |
| Mahler, F | 2 |
| Winkler, A | 1 |
| Jackson, RW | 1 |
| Benge, JM | 1 |
| van 't Laar, A | 1 |
| Lewis, P | 1 |
| Psaila, JV | 2 |
| Morgan, RH | 2 |
| Davies, WT | 2 |
| Woodcock, JP | 2 |
| Carolan, G | 1 |
| George, CF | 1 |
| Gjørup, T | 2 |
| Kelbaek, H | 2 |
| Hartling, OJ | 2 |
| White, CJ | 1 |
| Phillips, WA | 1 |
| Abrahams, LA | 1 |
| Watson, TD | 1 |
| Singleton, PT | 1 |
| Corbin, DO | 1 |
| Wood, DA | 1 |
| Macintyre, CC | 1 |
| Housley, E | 1 |
| Francis, DA | 2 |
| Aldoori, M | 1 |
| Campbell, WB | 1 |
| Dieppe, PA | 1 |
| Jonason, T | 1 |
| Kirch, W | 1 |
| Linder, HR | 1 |
| Hutt, HJ | 1 |
| Ohnhaus, EE | 1 |
| Scarpa, R | 1 |
| Rocco, P | 1 |
| Gioia, M | 1 |
| Fisher, J | 1 |
| Mack, RJ | 1 |
| Likier, HM | 1 |
| Schiff, AN | 1 |
| Borer, JS | 1 |
| Miller, FW | 1 |
| Love, LA | 1 |
| Mani, R | 1 |
| Roath, S | 1 |
| Bookman, AA | 1 |
| Mahon, W | 1 |
| Ramsay, C | 1 |
| Detsky, AS | 1 |
| Keystone, EC | 1 |
| Rivera Redondo, J | 1 |
| Noguerado Asensio, A | 1 |
| Alvaro-Gracia Alvaro, JM | 1 |
| Laffón Roca, A | 1 |
| Nakashima, Y | 1 |
| Fujihira, T | 1 |
| Fukuchi, Y | 1 |
| Ishii, N | 1 |
| Imaizumi, T | 1 |
| Miyahara, K | 1 |
| Takasugi, M | 1 |
| Kuroiwa, A | 1 |
| Thakur, SK | 1 |
| Gopinathan, VP | 1 |
| Jagdish, TK | 1 |
| Bhalla, IP | 1 |
| Shetty, KJ | 1 |
| Hawkins, SJ | 1 |
| Hall, ND | 1 |
| McGregor, A | 1 |
| Ring, EF | 1 |
| Maddison, PJ | 1 |
| Snedden, W | 1 |
| Fernandez, PG | 1 |
| Nath, C | 1 |
| Dawson, J | 1 |
| Ellis, WW | 1 |
| Baer, AN | 1 |
| Robertson, RM | 1 |
| Pincus, T | 1 |
| Kronenberg, MW | 1 |
| Matucci Cerinic, M | 1 |
| Falcini, F | 1 |
| Bartolozzi, G | 1 |
| Volpi, M | 1 |
| Foult, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)[NCT02506062] | 21 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| Potential Benefit for Non Invasive Vagus Nerve Stimulation (nVNS) Using GammaCore in the Treatment of Raynaud's Phenomena.[NCT03869008] | 7 participants (Actual) | Interventional | 2019-04-30 | Terminated (stopped due to Funding no longer available) | |||
| A Double-blinded, Placebo-controlled, Crossover Study to Assess Efficacy of Oral Treprostinil Titrated to Highest Tolerable Dose in 20 Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Resistant to Vasodilatory Therapy[NCT02583789] | Early Phase 1 | 12 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| A Randomized, Placebo-controlled Trial of St.John's Wort(a Natural Health Product) in the Treatment on Raynaud's Phenomenon[NCT00351117] | Phase 3 | 20 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| Identification of Transient Receptor Potential (TRP) Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.[NCT03211325] | 29 participants (Actual) | Interventional | 2016-10-18 | Completed | |||
| [NCT00000530] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
25 reviews available for nifedipine and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Drug Treatment of Raynaud's Phenomenon of the Nipple.
Topics: Breast Diseases; Breast Feeding; Calcium Channel Blockers; Female; Humans; Nifedipine; Nipples; Nitr | 2020 |
What is the Best Way to Treat Patients with Raynaud's Phenomenon and a Tendency towards Hypotension?
Topics: Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypotension; Losartan; Nifedipine; Nitrog | 2020 |
Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Topics: Calcium Channel Blockers; Dihydropyridines; Humans; Nifedipine; Pain Management; Placebos; Publicati | 2017 |
Raynaud's phenomenon (primary).
Topics: Administration, Oral; Humans; Nifedipine; Prevalence; Raynaud Disease; Ulcer; Vibration | 2013 |
Raynaud disease.
Topics: Calcium Channel Blockers; Cold Temperature; Delayed-Action Preparations; Enzyme Inhibitors; Female; | 2014 |
Calcium channel blockers for primary Raynaud's phenomenon.
Topics: Calcium Channel Blockers; Humans; Nicardipine; Nifedipine; Randomized Controlled Trials as Topic; Ra | 2014 |
Calcium channel blockers for primary Raynaud's phenomenon.
Topics: Calcium Channel Blockers; Humans; Nicardipine; Nifedipine; Randomized Controlled Trials as Topic; Ra | 2016 |
Raynaud's phenomenon (primary).
Topics: Administration, Oral; Humans; Nifedipine; Prevalence; Raynaud Disease; Ulcer; Vibration | 2008 |
Raynaud's phenomenon (primary).
Topics: Administration, Oral; Humans; Nifedipine; Prevalence; Raynaud Disease; Ulcer; Vibration | 2011 |
Raynaud's phenomenon (primary).
Topics: Amlodipine; Diltiazem; Humans; Nafronyl; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agent | 2003 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Raynaud's (primary).
Topics: Humans; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agents | 2003 |
Raynaud's phenomenon (primary).
Topics: Humans; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agents | 2004 |
Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon?
Topics: Adrenergic alpha-Antagonists; Evidence-Based Medicine; Humans; Nifedipine; Practice Guidelines as To | 2005 |
Raynaud's phenomenon (primary).
Topics: Humans; Nicardipine; Nifedipine; Raynaud Disease; Vasodilator Agents | 2005 |
Pharmacologic management of Raynaud's phenomenon.
Topics: Blood Platelets; Blood Viscosity; Fibrinogen; Griseofulvin; Humans; Methyldopa; Nifedipine; Parasymp | 1984 |
[Therapeutic (im)possibilities in Raynaud's phenomenon].
Topics: Algorithms; Combined Modality Therapy; Female; Humans; Male; Medical History Taking; Nifedipine; Phy | 1996 |
Pulvis de sclerotium and the mummified finger.
Topics: Algorithms; Arteriosclerosis; Calcium Channel Blockers; Ergotism; Humans; Nifedipine; Raynaud Diseas | 1997 |
Raynaud's phenomenon: state of the art 1998.
Topics: Biomarkers; Disease Progression; Humans; Nifedipine; Raynaud Disease; Vasodilator Agents | 1998 |
Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?
Topics: Adrenal Cortex Hormones; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmona | 2000 |
[Raynaud's phenomenon: clinical aspects of the disease].
Topics: Calcium Channel Blockers; Cold Temperature; Diagnosis, Differential; Female; Humans; Iloprost; Male; | 2001 |
Raynaud's syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Epoprostenol; Female; Humans; Ilopr | 1990 |
Use of nifedipine in hypertension and Raynaud's phenomenon.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Raynaud Disease | 1990 |
Raynaud's phenomenon.
Topics: Antibody Formation; Blood Vessels; Endothelium, Vascular; Fatty Acids, Essential; Humans; Inflammati | 1989 |
Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; | 1985 |
55 trials available for nifedipine and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Nifedipine cream versus sildenafil cream for patients with secondary Raynaud phenomenon: A randomized, double-blind, controlled pilot study.
Topics: Adolescent; Adult; Aged; Dosage Forms; Double-Blind Method; Female; Humans; Middle Aged; Nifedipine; | 2018 |
To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).
Topics: Adult; Delayed-Action Preparations; Female; Ginkgo biloba; Humans; Korea; Male; Middle Aged; Nifedip | 2009 |
Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
Topics: Administration, Sublingual; Adult; Cold Temperature; Cross-Over Studies; Double-Blind Method; Drug M | 2008 |
Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; | 1982 |
Nifedipine for Raynaud's phenomenon.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Nifedipine; Pyridines; Random A | 1983 |
[Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
Topics: Adult; Calcium; Clinical Trials as Topic; Cold Temperature; Connective Tissue Diseases; Double-Blind | 1982 |
Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; | 1983 |
Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon.
Topics: Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Nifedipine; Prospec | 1983 |
Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon).
Topics: Adult; Arthritis, Rheumatoid; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1983 |
[Calcium antagonists for the treatment of Raynaud's phenomenon].
Topics: Adult; Calcium Channel Blockers; Clinical Trials as Topic; Consumer Behavior; Double-Blind Method; F | 1983 |
[The effect of nifedipine (Adalat) on Raynaud's phenomenon].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1983 |
DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Nifedipine; Prazosin; Qu | 1984 |
Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifed | 1984 |
Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Female; Fingers; Humans; Male; Middle Aged; Nifedip | 1984 |
Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Double-Blind Method; Drug Evaluation; Female; Fingers; Humans; Imidazoles; Ma | 1984 |
Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Calcitonin Gene-Related Peptide; Corticotropin-Releasing Hormone; Erythrocyte | 1994 |
Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.
Topics: Administration, Oral; Adult; Blood Pressure; Blood Pressure Determination; Cold Temperature; Drug Ad | 1993 |
[Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
Topics: Adult; Aged; Alprostadil; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged | 1997 |
Behavioral and pharmacologic interventions: the Raynaud's Treatment Study.
Topics: Biofeedback, Psychology; Humans; Linear Models; Multivariate Analysis; Nifedipine; Randomized Contro | 1999 |
Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
Topics: Anticholesteremic Agents; Antioxidants; Ascorbic Acid; Cohort Studies; Humans; Lipoproteins; Lipopro | 1999 |
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
Topics: Adult; Aged; Female; Humans; Losartan; Male; Middle Aged; Nifedipine; Pilot Projects; Raynaud Diseas | 1999 |
Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up.
Topics: Adult; Biofeedback, Psychology; Body Temperature; Delayed-Action Preparations; Double-Blind Method; | 2000 |
Evaluation of treatment efficacy of Raynaud phenomenon by digital blood pressure response to cooling. Raynaud's Treatment Study Investigators.
Topics: Blood Pressure; Blood Pressure Monitors; Cold Temperature; Delayed-Action Preparations; Feedback, Ph | 2000 |
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Topics: Adult; Aged; Cold Temperature; Cross-Over Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Ni | 2001 |
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Topics: Adult; Aged; Cold Temperature; Cross-Over Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Ni | 2001 |
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Topics: Adult; Aged; Cold Temperature; Cross-Over Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Ni | 2001 |
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Topics: Adult; Aged; Cold Temperature; Cross-Over Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Ni | 2001 |
Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease.
Topics: Adolescent; Adult; Blood Pressure; Cold Temperature; Double-Blind Method; Female; Heart Rate; Hemody | 1990 |
Use of nifedipine in hypertension and Raynaud's phenomenon.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Raynaud Disease | 1990 |
[Correction of microcirculatory disorders in rheumatic diseases].
Topics: Administration, Oral; Clinical Trials as Topic; Dextrans; Dipyridamole; Disseminated Intravascular C | 1985 |
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Topics: Administration, Oral; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Metho | 1989 |
Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Ketanserin; Male; Middle Aged; Nifedipine; Ra | 1989 |
Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; | 1989 |
The clinical effect of felodipine and nifedipine in Raynaud's phenomenon.
Topics: Adolescent; Adult; Child; Child, Preschool; Double-Blind Method; Felodipine; Female; Humans; Infant; | 1989 |
A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; | 1988 |
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; beta-Thromboglobulin; Blood Platelets; Double-Blind Meth | 1985 |
The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Nifedipine; Nisoldipine; P | 1988 |
[Treatment of Raynaud's syndrome with calcium entry blockers].
Topics: Adolescent; Adult; Calcium Channel Blockers; Clinical Trials as Topic; Female; Fendiline; Humans; Ma | 1987 |
Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Fingers; Humans; Male; | 1987 |
Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Nifedipine; Raynaud Disease; Time Factors | 1987 |
Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
Topics: Blood Flow Velocity; Clinical Trials as Topic; Double-Blind Method; Humans; Nifedipine; Raynaud Dise | 1987 |
[Use of nifedipine in patients with Raynaud's phenomenon].
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Nifedipine; Raynaud | 1987 |
Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Flow Velocity; Female; Hemodynamics; Humans; Ma | 1987 |
Nifedipine in patients with Raynaud's syndrome--effects on radial artery blood flow.
Topics: Administration, Sublingual; Adult; Aged; Blood Flow Velocity; Cold Temperature; Echocardiography; Ex | 1987 |
Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Female; Headache; Humans; Male | 1986 |
Objective benefit of nifedipine in the treatment of Raynaud's phenomenon. Double-blind controlled study.
Topics: Adult; Aged; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Humans | 1986 |
A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Fingers; H | 1986 |
Clinical and rheological effects of nifedipine in Raynaud's phenomenon.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Erythrocyte Deformability; Female; Humans; Male; | 1986 |
Nifedipine in the treatment of Raynaud's syndrome.
Topics: Adult; Aged; Arteries; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle A | 1986 |
The effect of the calcium-entry blocker nifedipine on cold-induced digital vasospasm. A double-blind crossover study versus placebo.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Cold Temperature; Double-Blind Method; Female; Fing | 1987 |
Ketanserin versus nifedipine in secondary Raynaud's phenomenon.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Humans; Ketanserin; Male; Middle Aged; Nifedipi | 1987 |
Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
Topics: Adult; Cold Temperature; Female; Fingers; Humans; Longitudinal Studies; Male; Middle Aged; Nifedipin | 1987 |
Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Topics: Adult; Cold Temperature; Double-Blind Method; Female; Fingers; Humans; Imidazoles; Lupus Erythematos | 1987 |
Nisoldipine in primary Raynaud's phenomenon.
Topics: Adult; Aged; Calcium Channel Blockers; Drug Evaluation; Drug Tolerance; Erythrocyte Deformability; F | 1987 |
Nifedipine in the treatment of idiopathic Raynaud's syndrome.
Topics: Adult; Drug Tolerance; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Plethysmography; | 1986 |
The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
Topics: Adolescent; Adult; Aged; Female; Fingers; Humans; Male; Middle Aged; Nifedipine; Raynaud Disease; Re | 1986 |
Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
Topics: Adult; Calcium Channel Blockers; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle | 1986 |
Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; | 1985 |
78 other studies available for nifedipine and Cold Fingers, Hereditary
| Article | Year |
|---|---|
Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database.
Topics: Drug Repositioning; Humans; Nifedipine; Pharmacovigilance; Raynaud Disease; World Health Organizatio | 2020 |
Digit Ulcerations in a Young Woman.
Topics: Female; Fingers; Humans; Ischemia; Nifedipine; Photography; Raynaud Disease; Scleroderma, Systemic; | 2020 |
Raynaud phenomenon of the nipple successfully treated with nifedipine and gabapentin.
Topics: Adult; Breast Diseases; Breast Feeding; Female; Gabapentin; Humans; Nifedipine; Nipples; Pain; Rayna | 2020 |
A Rare Case of Kikuchi-Fujimoto Disease Associated with Systemic Lupus Erythematosus.
Topics: Adolescent; Asian People; Fever; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, | 2018 |
Raynaud Phenomenon of the Nipple: An Under-Recognized Condition.
Topics: Adult; Breast Diseases; Diagnosis, Differential; Female; Humans; Nifedipine; Nipples; Pain; Pregnanc | 2019 |
Antioxidant agents help primary Raynaud's phenomenon.
Topics: Adult; Antioxidants; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Male; Micr | 2015 |
Successfully treated fingertip necrosis in an infant with primary Raynaud phenomenon.
Topics: Anticoagulants; Drug Therapy, Combination; Enoxaparin; Fingers; Humans; Infant; Male; Necrosis; Nife | 2014 |
Difficulties in diagnosis and treatment of severe secondary Raynaud's phenomenon in a Cameroonian woman: a case report.
Topics: Adult; Analgesics, Opioid; Anti-Bacterial Agents; Black People; Calcium Channel Blockers; Cloxacilli | 2016 |
[Diagnostic image. A breastfeeding woman with a painful, blue nipple].
Topics: Adult; Breast Feeding; Calcium Channel Blockers; Female; Humans; Nifedipine; Nipples; Raynaud Diseas | 2009 |
[Diagnostic image. A breastfeeding woman with a painful, blue nipple].
Topics: Adult; Breast Feeding; Calcium Channel Blockers; Female; Humans; Nifedipine; Nipples; Raynaud Diseas | 2009 |
[Treatment options of acral ulcers in MCTD].
Topics: Adult; Amides; Analgesia, Patient-Controlled; Angiography, Digital Subtraction; Autonomic Nerve Bloc | 2010 |
Raynaud phenomenon of the nipple: a rare finding in rheumatology clinic.
Topics: Adult; Breast Diseases; Breast Feeding; Cold Temperature; Color; Female; Humans; Mastodynia; Nifedip | 2011 |
Syncope and Raynaud's disease.
Topics: Adult; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nifedipine; Raynaud Disease; Syncope | 2012 |
Raynaud's phenomenon of the nipple.
Topics: Adult; Breast Feeding; Female; Humans; Nifedipine; Nipples; Pain; Raynaud Disease; Vasodilator Agent | 2012 |
Innovative designs in behavioural trials.
Topics: Behavior; Biofeedback, Psychology; Data Interpretation, Statistical; Electromyography; Humans; Nifed | 2002 |
Nipple vasospasms, Raynaud's syndrome, and nifedipine.
Topics: Adult; Female; Humans; Muscle, Smooth, Vascular; Nifedipine; Nipples; Raynaud Disease; Spasm; Vascul | 2002 |
Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
Topics: Adult; Breast Diseases; Breast Feeding; Candidiasis; Diagnostic Errors; Female; Humans; Nifedipine; | 2004 |
Vasospasm of the nipple presenting as painful lactation.
Topics: Adult; Breast Feeding; Female; Humans; Lactation; Nifedipine; Nipples; Pain; Raynaud Disease; Vascul | 2006 |
Anorexia nervosa and Raynaud's phenomenon: a case report.
Topics: Administration, Cutaneous; Adult; Amenorrhea; Anorexia Nervosa; Aspirin; Bone Density; Bone Diseases | 2007 |
Combined systolic and diastolic heart failure as the first presentation of mixed connective tissue disease.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diu | 2007 |
Resolution of chronic pain and fingertip ulceration due to hand-arm vibration syndrome following combination pharmacotherapy.
Topics: Chronic Disease; Drug Therapy, Combination; Hand-Arm Vibration Syndrome; Humans; Male; Middle Aged; | 2007 |
Nifedipine treatment for Raynaud's phenomenon.
Topics: Humans; Nifedipine; Raynaud Disease | 1984 |
Effect of nifedipine in Raynaud's disease: a case report.
Topics: Adult; Female; Humans; Nifedipine; Plethysmography; Raynaud Disease | 1984 |
Nifedipine as a therapeutic modality for Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Creatinine; Double-Blind Method; Female; Fingers; Humans; Male; Middle Aged; | 1983 |
Treatment of digital vasospastic disease with the calcium-entry blocker nifedipine.
Topics: Adult; Arteries; Arterioles; Blood Pressure; Calcium Channel Blockers; Fingers; Humans; Male; Middle | 1984 |
The use of longterm nifedipine in a patient with Raynaud's syndrome secondary to mixed connective tissue disease.
Topics: Adult; Humans; Male; Mixed Connective Tissue Disease; Nifedipine; Raynaud Disease; Time Factors | 1984 |
Raynaud's disease and nifedipine.
Topics: Female; Humans; Middle Aged; Nifedipine; Pyridines; Raynaud Disease | 1983 |
Nifedipine: two new uses.
Topics: Humans; Hypertension, Malignant; Nifedipine; Pyridines; Raynaud Disease | 1983 |
Nifedipine in digital ulceration in scleroderma.
Topics: Adult; Female; Humans; Nifedipine; Pyridines; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer | 1982 |
Nifedipine and Raynaud's phenomenon.
Topics: Female; Humans; Male; Nifedipine; Pyridines; Raynaud Disease | 1981 |
[The use of capillary videomicroscopy in the therapeutic assessment of acral vasospastic phenomena: microcirculatory effect of ketanserin and nifedipine].
Topics: Capillaries; Humans; Ketanserin; Microcirculation; Microscopy; Nifedipine; Raynaud Disease; Video Re | 1994 |
Effects of cold pressor test on circulating atrial natriuretic peptide 99-126 (ANP) in patients with Raynaud's phenomenon and influence of treatment with magnesium sulphate and nifedipine.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Cold Temperature; Female; Humans; Magnesium Sulfat | 1993 |
Geriatrics photo quiz. Raynaud's: classic "blue fingertips'.
Topics: Adult; Aged; Calcium Channel Blockers; Diagnosis, Differential; Female; Humans; Iloprost; Male; Midd | 1996 |
Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: color Doppler flow imaging study.
Topics: Adult; Captopril; Cold Temperature; Female; Fingers; Humans; Male; Nifedipine; Nitroglycerin; Pulsat | 1996 |
Possible erythromelalgia-like syndrome associated with nifedipine in a patient with Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Erythromelalgia; Female; Heart Rate; Humans; Nifedipine; Raynaud Disease | 1996 |
Raynaud's phenomenon of the nipple: a preventable cause of breastfeeding failure?
Topics: Breast Feeding; Female; Humans; Nifedipine; Nipples; Raynaud Disease; Vasodilator Agents | 1997 |
Rational use of calcium-channel antagonists in Raynaud's phenomenon.
Topics: Amlodipine; Calcium Channel Blockers; Diltiazem; Felodipine; Humans; Isradipine; Nicardipine; Nifedi | 1998 |
[Laser Doppler spectral analysis of patients with Raynaud's phenomenon during a standardized thermal test].
Topics: Female; Hand; Hot Temperature; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Nifedipine; | 1998 |
Higher-order spectral analysis in laser-Doppler flowmetry signal processing.
Topics: Adult; Artifacts; Case-Control Studies; Female; Finite Element Analysis; Fourier Analysis; Humans; L | 1999 |
Spectral analysis of laser-Doppler perfusion signal measured during thermal test.
Topics: Adult; Algorithms; Case-Control Studies; Cold Temperature; Female; Humans; Laser-Doppler Flowmetry; | 1999 |
Dynamic characteristics of laser-Doppler flux in normal individuals and patients with Raynaud's phenomenon before and after treatment with nifedipine under different thermal conditions.
Topics: Algorithms; Case-Control Studies; Cold Temperature; Fingers; Humans; Laser-Doppler Flowmetry; Microc | 1999 |
Linear and nonlinear analysis of blood flow in healthy subjects and in subjects with Raynaud's phenomenon.
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Case-Control Studies; Cold Temperature; Fourier Analys | 1999 |
[Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Calcium; Coronary Disease; Hu | 1977 |
Nifedipine induced gingival abscesses.
Topics: Adult; Female; Gingival Diseases; Humans; Nifedipine; Periodontal Abscess; Raynaud Disease | 1992 |
Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon.
Topics: Connective Tissue Diseases; Humans; Iloprost; Infusions, Intravenous; Nifedipine; Raynaud Disease; R | 1991 |
Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Topics: Adult; Blood Pressure; Calcinosis; Cardiac Catheterization; Cardiac Output; Dyspnea; Esophageal Moti | 1991 |
The phenomenon, syndrome and disease of Maurice Raynaud.
Topics: Antibodies, Antinuclear; Autoantibodies; Blood Circulation; Blood Vessels; Humans; Microcirculation; | 1990 |
Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.
Topics: Adult; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Iloprost; Middle Aged; | 1985 |
Acute effects of sublingual nifedipine in patients with Raynaud's phenomenon.
Topics: Administration, Oral; Adult; Aged; Female; Hand; Humans; Male; Middle Aged; Mouth Floor; Nifedipine; | 1987 |
Nifedipine in the treatment of Raynaud's disease in childhood.
Topics: Administration, Sublingual; Adolescent; Child; Drug Evaluation; Female; Humans; Nifedipine; Raynaud | 1989 |
[Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Topics: Adult; Cold Temperature; Female; Humans; Hyperemia; Ischemia; Male; Middle Aged; Nifedipine; Raynaud | 1989 |
Raynaud's phenomenon and nifedipine.
Topics: Humans; Nifedipine; Pain; Raynaud Disease | 1989 |
Decreased rectal body temperature induced by different vasodilatory drugs.
Topics: Adult; Epoprostenol; Female; Humans; Hypertension; Hypothermia; Middle Aged; Nifedipine; Prazosin; R | 1989 |
[Treatment of vibration-induced disease with corinfar].
Topics: Humans; Nifedipine; Occupational Diseases; Raynaud Disease; Vibration | 1989 |
[Capillaroscopic evaluation of the effects of nifedipine in patients with Raynaud's phenomenon].
Topics: Adult; Aged; Capillaries; Female; Hand; Humans; Male; Microscopy; Middle Aged; Nifedipine; Raynaud D | 1988 |
Raynaud's disease.
Topics: Antihypertensive Agents; Child; Dinoprostone; Epoprostenol; Female; Humans; Ketanserin; Male; Nifedi | 1985 |
Nifedipine treatment of Raynaud's phenomenon secondary to chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Nifedipine; Raynaud Diseas | 1988 |
Reduction of pulmonary capillary blood volume following cold exposure in patients with Raynaud's phenomenon.
Topics: Adult; Aged; Blood Volume; Capillaries; Carbon Monoxide; Cold Temperature; Female; Fingers; Humans; | 1988 |
Reactive hyperemia in patients with Raynaud's phenomenon.
Topics: Adolescent; Adult; Female; Fingers; Humans; Hyperemia; Male; Middle Aged; Nifedipine; Plethysmograph | 1988 |
[Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
Topics: Blood Circulation; Calcium Channel Blockers; Connective Tissue Diseases; Drug Evaluation; Fendiline; | 1988 |
Nifedipine and oncologic Raynaud phenomenon.
Topics: Antineoplastic Agents; Humans; Male; Nifedipine; Raynaud Disease; Testicular Neoplasms | 1988 |
[The use of calcium antagonists in the treatment of ocular circulation symptoms in the framework of a vasospastic syndrome].
Topics: Calcium Channel Blockers; Humans; Nifedipine; Raynaud Disease; Retinal Diseases; Vasoconstriction; V | 1988 |
Value and limitations of calcium channel blockade in the treatment of pulmonary hypertension associated with CREST--case reports.
Topics: Adult; Calcinosis; Diltiazem; Esophageal Diseases; Female; Humans; Hypertension, Pulmonary; Male; Mi | 1988 |
Digital and radial artery blood flow in patients with Raynaud's phenomenon in response to nifedipine.
Topics: Adult; Arm; Double-Blind Method; Female; Fingers; Humans; Male; Nifedipine; Plethysmography; Raynaud | 1987 |
Nifedipine: a calcium channel blocking drug.
Topics: Angina Pectoris; Humans; Hypertension; Nifedipine; Raynaud Disease | 1987 |
Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
Topics: Adult; Aged; Body Temperature; Female; Humans; Male; Middle Aged; Nifedipine; Raynaud Disease; Scler | 1987 |
Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
Topics: Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Pulmonary Wedg | 1987 |
Prevention of predictable Raynaud's phenomenon by sublingual nifedipine.
Topics: Administration, Sublingual; Adult; Female; Humans; Nifedipine; Raynaud Disease | 1987 |
Nifedipine and distal gangrene in Raynaud's phenomenon.
Topics: Adult; Female; Gangrene; Humans; Nifedipine; Raynaud Disease | 1986 |
Autopsy findings of the coronary arteries of variant angina with Raynaud's phenomenon of the tongue.
Topics: Adult; Alprostadil; Angina Pectoris, Variant; Cardiac Catheterization; Coronary Vessels; Drug Therap | 1986 |
Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
Topics: Adult; Female; Humans; Nifedipine; Raynaud Disease; Scleroderma, Systemic | 1986 |
Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Female; Humans; Lymphocyte Activation; Lymphocyte | 1986 |
The metabolism of nifedipine during long-term therapy.
Topics: Chemical Phenomena; Chemistry; Female; Humans; Hypertension; Male; Nifedipine; Osmolar Concentration | 1986 |
Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis.
Topics: Adult; Cold Temperature; Female; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Hypothermia | 1986 |
Treatment of Raynaud's phenomenon with calcium channel blockers.
Topics: Calcium Channel Blockers; Diltiazem; Female; Fingers; Humans; Muscle Relaxation; Muscle, Smooth, Vas | 1985 |
Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
Topics: Child; Female; Humans; Nifedipine; Raynaud Disease | 1985 |
[Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)].
Topics: Adult; Female; Fingers; Humans; Male; Middle Aged; Nifedipine; Raynaud Disease; Regional Blood Flow; | 1985 |
Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Humans; Male; Nifedipine; Phenylephrine; Prazosi | 1985 |